Literature DB >> 18602022

The early- and late stages in phenotypic modulation of vascular smooth muscle cells: differential roles for lysophosphatidic acid.

Huazhang Guo1, Natalia Makarova, Yunhui Cheng, Shuyu E, Rui-Rui Ji, Chunxiang Zhang, Patricia Farrar, Gabor Tigyi.   

Abstract

Lysophosphatidic acid (LPA) has been implicated as causative in phenotypic modulation (PM) of cultured vascular smooth muscle cells (VSMC) in their transition to the dedifferentiated phenotype. We evaluated the contribution of the three major LPA receptors, LPA1 and LPA2 GPCR and PPARgamma, on PM of VSMC. Expression of differentiated VSMC-specific marker genes, including smooth muscle alpha-actin, smooth muscle myosin heavy chain, calponin, SM-22alpha, and h-caldesmon, was measured by quantitative real-time PCR in VSMC cultures and aortic rings kept in serum-free chemically defined medium or serum- or LPA-containing medium using wild-type C57BL/6, LPA1, LPA2, and LPA1&2 receptor knockout mice. Within hours after cells were deprived of physiological cues, the expression of VSMC marker genes, regardless of genotype, rapidly decreased. This early PM was neither prevented by IGF-I, inhibitors of p38, ERK1/2, or PPARgamma nor significantly accelerated by LPA or serum. To elucidate the mechanism of PM in vivo, carotid artery ligation with/without replacement of blood with Krebs solution was used to evaluate contributions of blood flow and pressure. Early PM in the common carotid was induced by depressurization regardless of the presence/absence of blood, but eliminating blood flow while maintaining blood pressure or after sham surgery elicited no early PM. The present results indicate that LPA, serum, dissociation of VSMC, IGF-I, p38, ERK1/2, LPA1, and LPA2 are not causative factors of early PM of VSMC. Tensile stress generated by blood pressure may be the fundamental signal maintaining the fully differentiated phenotype of VSMC.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18602022      PMCID: PMC3446793          DOI: 10.1016/j.bbalip.2008.06.003

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  82 in total

Review 1.  The smooth muscle cell in culture.

Authors:  J Chamley-Campbell; G R Campbell; R Ross
Journal:  Physiol Rev       Date:  1979-01       Impact factor: 37.312

2.  Morphological studies of cultured swine aorta media explants.

Authors:  G L Rossi; J Alroy; S Röthenmund
Journal:  Virchows Arch B Cell Pathol       Date:  1973-01-31

Review 3.  Regulation of differentiation of vascular smooth muscle cells.

Authors:  G K Owens
Journal:  Physiol Rev       Date:  1995-07       Impact factor: 37.312

4.  Stretch affects phenotype and proliferation of vascular smooth muscle cells.

Authors:  K G Birukov; V P Shirinsky; O V Stepanova; V A Tkachuk; A W Hahn; T J Resink; V N Smirnov
Journal:  Mol Cell Biochem       Date:  1995-03-23       Impact factor: 3.396

5.  Structure and expression of a smooth muscle cell-specific gene, SM22 alpha.

Authors:  J Solway; J Seltzer; F F Samaha; S Kim; L E Alger; Q Niu; E E Morrisey; H S Ip; M S Parmacek
Journal:  J Biol Chem       Date:  1995-06-02       Impact factor: 5.157

6.  Mechanical stress-induced orientation and ultrastructural change of smooth muscle cells cultured in three-dimensional collagen lattices.

Authors:  K Kanda; T Matsuda
Journal:  Cell Transplant       Date:  1994 Nov-Dec       Impact factor: 4.064

7.  Vascular smooth muscle cells differ from other smooth muscle cells: predominance of vimentin filaments and a specific alpha-type actin.

Authors:  G Gabbiani; E Schmid; S Winter; C Chaponnier; C de Ckhastonay; J Vandekerckhove; K Weber; W W Franke
Journal:  Proc Natl Acad Sci U S A       Date:  1981-01       Impact factor: 11.205

8.  Insulin receptor substrate-1/SHP-2 interaction, a phenotype-dependent switching machinery of insulin-like growth factor-I signaling in vascular smooth muscle cells.

Authors:  Ken'ichiro Hayashi; Katsushi Shibata; Tsuyoshi Morita; Kazuhiro Iwasaki; Masahiro Watanabe; Kenji Sobue
Journal:  J Biol Chem       Date:  2004-07-21       Impact factor: 5.157

9.  Stretch of the vascular wall induces smooth muscle differentiation by promoting actin polymerization.

Authors:  Sebastian Albinsson; Ina Nordström; Per Hellstrand
Journal:  J Biol Chem       Date:  2004-06-07       Impact factor: 5.157

10.  Phenotype-dependent response of cultured aortic smooth muscle to serum mitogens.

Authors:  J H Chamley-Campbell; G R Campbell; R Ross
Journal:  J Cell Biol       Date:  1981-05       Impact factor: 10.539

View more
  9 in total

1.  Lysophosphatidic acid effects on atherosclerosis and thrombosis.

Authors:  Mei-Zhen Cui
Journal:  Clin Lipidol       Date:  2011-08

Review 2.  An overview of potential molecular mechanisms involved in VSMC phenotypic modulation.

Authors:  Ming-Jie Zhang; Yi Zhou; Lei Chen; Yan-Qin Wang; Xu Wang; Yan Pi; Chang-Yue Gao; Jing-Cheng Li; Li-Li Zhang
Journal:  Histochem Cell Biol       Date:  2015-12-26       Impact factor: 4.304

3.  Disruption of actin cytoskeleton mediates loss of tensile stress induced early phenotypic modulation of vascular smooth muscle cells in organ culture.

Authors:  Jian-Pu Zheng; Donghong Ju; Jianbin Shen; Maozhou Yang; Li Li
Journal:  Exp Mol Pathol       Date:  2009-10-27       Impact factor: 3.362

4.  TSH stimulates the proliferation of vascular smooth muscle cells.

Authors:  Limin Tian; Jing Ni; Tiankang Guo; Jing Liu; Yamei Dang; Qian Guo; Luyan Zhang
Journal:  Endocrine       Date:  2014-01-23       Impact factor: 3.633

5.  Activation of human vascular cells decreases their expression of transforming growth factor-beta.

Authors:  Amir H Lebastchi; Lingfeng Qin; Salman F Khan; Jing Zhou; Arnar Geirsson; Richard W Kim; Wei Li; George Tellides
Journal:  Atherosclerosis       Date:  2011-08-05       Impact factor: 5.162

6.  LPA receptor 4 deficiency attenuates experimental atherosclerosis.

Authors:  Liping Yang; Maria Kraemer; Xianjun Frank Fang; Peggi M Angel; Richard R Drake; Andrew J Morris; Susan S Smyth
Journal:  J Lipid Res       Date:  2019-02-22       Impact factor: 5.922

7.  Lysophosphatidic acid-induced arterial wall remodeling: requirement of PPARgamma but not LPA1 or LPA2 GPCR.

Authors:  Yunhui Cheng; Natalia Makarova; Ryoko Tsukahara; Huazhang Guo; E Shuyu; Patricia Farrar; Louisa Balazs; Chunxiang Zhang; Gabor Tigyi
Journal:  Cell Signal       Date:  2009-08-23       Impact factor: 4.315

8.  Mitigation of radiation injury by selective stimulation of the LPA(2) receptor.

Authors:  Gyöngyi N Kiss; Sue-Chin Lee; James I Fells; Jianxiong Liu; William J Valentine; Yuko Fujiwara; Karin Emmons Thompson; Charles R Yates; Balázs Sümegi; Gabor Tigyi
Journal:  Biochim Biophys Acta       Date:  2013-01

Review 9.  Lysophosphatidic acid in atherosclerotic diseases.

Authors:  Andreas Schober; Wolfgang Siess
Journal:  Br J Pharmacol       Date:  2012-10       Impact factor: 8.739

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.